Perry A Karsen Graphite Bio, Inc. (GRPH) insider trading activity

GRPH Quotes by TradingView

Perry A Karsen is Director of Graphite Bio, Inc.. Currently has a direct ownership of 164,034 shares of GRPH, which is worth approximately $0. The most recent transaction as insider was on Jun 29, 2021, when has been sold 8,126 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 164K
0% 3M change
0% 12M change
Total Value Held $0

PERRY A KARSEN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 29 2021
BUY
Conversion of derivative security
-
8,126 Added 4.72%
164,034 Common Stock

Also insider at

NTLA
Intellia Therapeutics, Inc. Healthcare
Director
JNCE
Jounce Therapeutics, Inc. Healthcare
Director
PAK

Perry A Karsen

Director
Cambridge, MA

Track Institutional and Insider Activities on GRPH

Follow Graphite Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GRPH shares.

Notify only if

Insider Trading

Get notified when an Graphite Bio, Inc. insider buys or sells GRPH shares.

Notify only if

News

Receive news related to Graphite Bio, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GRPH